Sandoz Inc recalls Losartan — Potassium Hydrochlorothiazide
- Recall date
- November 9, 2018
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Sandoz Inc, Losartan
Why it was recalled
Due to detection of NDEA (N-Nitrosodiethylamine) Impurity — Potential Lack of Sterility
What was recalled
Potassium Hydrochlorothiazide
Read the official recall notice →
Get recall alerts
Free email alert whenever Sandoz Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sandoz Inc, Losartan